Bio-Gate Past Earnings Performance
Past criteria checks 0/6
Bio-Gate's earnings have been declining at an average annual rate of -13.8%, while the Chemicals industry saw earnings growing at 17.5% annually. Revenues have been growing at an average rate of 14.7% per year.
Key information
-13.8%
Earnings growth rate
-5.6%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 14.7% |
| Return on equity | -47.6% |
| Net Margin | -22.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses Breakdown
How Bio-Gate makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 7 | -2 | 3 | 0 |
| 30 Sep 23 | 7 | -2 | 3 | 0 |
| 30 Jun 23 | 7 | -1 | 3 | 0 |
| 31 Mar 23 | 6 | -2 | 3 | 0 |
| 31 Dec 22 | 6 | -2 | 3 | 0 |
| 30 Sep 22 | 6 | -2 | 3 | 0 |
| 30 Jun 22 | 6 | -2 | 3 | 0 |
| 31 Mar 22 | 6 | -1 | 3 | 0 |
| 31 Dec 21 | 6 | -1 | 2 | 0 |
| 30 Sep 21 | 6 | -1 | 2 | 0 |
| 30 Jun 21 | 6 | -1 | 2 | 0 |
| 31 Mar 21 | 6 | -1 | 2 | 0 |
| 31 Dec 20 | 5 | -1 | 2 | 0 |
| 30 Sep 20 | 5 | -1 | 2 | 0 |
| 30 Jun 20 | 5 | -1 | 2 | 0 |
| 31 Mar 20 | 4 | -1 | 2 | 0 |
| 31 Dec 19 | 4 | -1 | 2 | 0 |
| 30 Sep 19 | 3 | -1 | 2 | 0 |
| 30 Jun 19 | 3 | -1 | 2 | 0 |
| 31 Mar 19 | 4 | -1 | 2 | 0 |
| 31 Dec 18 | 4 | -1 | 2 | 0 |
| 30 Sep 18 | 4 | -1 | 2 | 0 |
| 30 Jun 18 | 5 | 0 | 2 | 0 |
| 31 Mar 18 | 4 | 0 | 2 | 0 |
| 31 Dec 17 | 4 | 0 | 2 | 0 |
| 30 Sep 17 | 4 | 0 | 2 | 0 |
| 30 Jun 17 | 4 | 0 | 2 | 0 |
| 31 Mar 17 | 4 | 0 | 2 | 0 |
| 31 Dec 16 | 4 | 0 | 1 | 0 |
| 30 Sep 16 | 4 | 0 | 1 | 0 |
| 30 Jun 16 | 4 | 0 | 1 | 0 |
| 31 Mar 16 | 3 | 0 | 1 | 0 |
| 31 Dec 15 | 3 | -1 | 1 | 0 |
| 30 Sep 15 | 3 | -1 | 1 | 0 |
| 30 Jun 15 | 3 | -1 | 1 | 0 |
| 31 Mar 15 | 2 | -1 | 1 | 0 |
| 31 Dec 14 | 2 | -1 | 1 | 0 |
| 30 Sep 14 | 2 | -2 | 1 | 0 |
| 30 Jun 14 | 2 | -2 | 2 | 0 |
| 31 Mar 14 | 2 | -2 | 2 | 0 |
| 31 Dec 13 | 2 | -2 | 2 | 0 |
| 30 Sep 13 | 3 | -2 | 2 | 0 |
Quality Earnings: BIG1 is currently unprofitable.
Growing Profit Margin: BIG1 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIG1 is unprofitable, and losses have increased over the past 5 years at a rate of 13.8% per year.
Accelerating Growth: Unable to compare BIG1's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BIG1 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (5%).
Return on Equity
High ROE: BIG1 has a negative Return on Equity (-47.58%), as it is currently unprofitable.